Drugs
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 12/16/14 -- Flamel Technologies (NASDAQ: FLML) announced today that it is moving all intangible property from its French entity to its Irish-based entity as a part of ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/16/14 -- VANC Pharmaceuticals Inc. ("Vanc" or the "Company") (TSX VENTURE: NPH)(OTCQB: NUVPF) is pleased to announce that it ha ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 12/16/14 -- Knight Therapeutics Inc. (TSX: GUD), through one of its wholly owned subsidiaries ("Knight"), announced today that it has committed to inve ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 12/15/14 -- The Board of Directors of Merus Labs International Inc. ("Merus" or the "Company") (TSX: MSL)(NASDAQ: MSLI) is pleased to announc ...
NEW YORK, NY: KD025 Among Therapeutic Candidates Representing the Future of Lupus Treatment ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/10/14 -- VANC Pharmaceuticals Inc. (TSX VENTURE: NPH)(OTCQB: NUVPF) ("VANC" or the "Company"), a pharmaceutical company focused ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 12/09/14 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") announced today, through its U.S. opera ...
BOTHELL, WA: SMARTICLES(R) Formulated PNT2258 Achieved Meaningful Therapeutic Outcomes ...
PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 12/09/14 -- Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery ...
SAN FRANCISCO, CA: KD025 a Potential Novel Therapeutic Approach to Treating Chronic GVHD ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/08/14 -- VANC Pharmaceuticals Inc. ("VANC" or the "Company") (TSX VENTURE: NPH)(OTCQB: NUVPF), a pharmaceutical company focused ...
SOUTH SAN FRANCISCO, CA: Groundbreaking Chronic Prophylactic Treatment for SCD Is Focus of Oral and Poster Presentations, Data Paves Way for Advancing GBT440 Into Clinical Studies ...
PHOENIX, AZ: PHOENIX, AZ -- (Marketwired) -- 12/04/14 -- Independent comparison analyses have found that cannabidiol (CBD) synthetically produced by Insys Therapeutics, Inc. (NASDAQ: INSY) is chemically identical ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/03/14 -- NeutriSci International Inc. (TSX VENTURE: NU) (the "Company" or "NeutriSci"), formerly known as Disani Capital Corp. ...
CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwired) -- 12/03/14 -- Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with orphan a ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 12/02/14 -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today that it has entered in ...
SOUTH SAN FRANCISCO, CA: Groundbreaking Disease-Modifying Treatment for SCD Is Focus of Oral and Poster Presentations ...
SAN DIEGO, CA: Dr. Christine Ichim to Discuss In Vivo Validation of Cancer Stem Cell Gene Target; Peer-Reviewed Support for NR2F6 (EAR-2) Nuclear Receptor Inhibition as a Means to "Kill Cancer at Its Root" ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 11/25/14 -- Medivation, Inc. (NASDAQ: MDVN) today announced that Joseph Lobacki will join the company as chief commercial officer on December 8, 2014. In this po ...
SAN DIEGO, CA: Company Aims to Use Small Molecule and Gene Silencing to Target "Root" of Cancer ...
